2023 Q4 Form 10-Q Financial Statement

#000003260424000008 Filed on February 07, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $4.117B $4.090B
YoY Change 22.06% -23.69%
Cost Of Revenue $2.201B $2.078B
YoY Change 25.56% -31.71%
Gross Profit $1.916B $2.012B
YoY Change 18.27% -13.16%
Gross Profit Margin 46.54% 49.19%
Selling, General & Admin $1.277B $1.114B
YoY Change 23.98% -1.94%
% of Gross Profit 66.65% 55.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $422.0M $271.0M
YoY Change 62.31% -14.51%
% of Gross Profit 22.03% 13.47%
Operating Expenses $1.277B $1.206B
YoY Change 23.98% -9.12%
Operating Profit $639.0M $806.0M
YoY Change 8.31% -18.59%
Interest Expense -$44.00M $150.0M
YoY Change -8.33% -383.02%
% of Operating Profit -6.89% 18.61%
Other Income/Expense, Net $20.00M
YoY Change -54.55%
Pretax Income $139.0M $904.0M
YoY Change -67.06% 0.0%
Income Tax $7.000M $209.0M
% Of Pretax Income 5.04% 23.12%
Net Earnings $142.0M $744.0M
YoY Change -93.91% 0.54%
Net Earnings / Revenue 3.45% 18.19%
Basic Earnings Per Share $0.25 $1.30
Diluted Earnings Per Share $0.25 $1.29
COMMON SHARES
Basic Shares Outstanding 570.1M shares
Diluted Shares Outstanding 573.3M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.076B $8.051B
YoY Change -8.59% 346.29%
Cash & Equivalents $2.076B $8.051B
Short-Term Investments
Other Short-Term Assets $1.399B $1.244B
YoY Change 8.45% -17.23%
Inventory $2.432B $2.006B
Prepaid Expenses
Receivables $2.759B $2.518B
Other Receivables $0.00 $0.00
Total Short-Term Assets $8.666B $13.82B
YoY Change -3.71% 62.46%
LONG-TERM ASSETS
Property, Plant & Equipment $2.701B $2.363B
YoY Change 19.35% -29.69%
Goodwill $17.98B $14.48B
YoY Change 27.66% -1.24%
Intangibles $11.27B $6.263B
YoY Change 74.46% -6.86%
Long-Term Investments
YoY Change
Other Assets $2.640B $2.566B
YoY Change 16.4% 6.08%
Total Long-Term Assets $37.85B $28.93B
YoY Change 38.93% 6.48%
TOTAL ASSETS
Total Short-Term Assets $8.666B $13.82B
Total Long-Term Assets $37.85B $28.93B
Total Assets $46.51B $42.75B
YoY Change 28.34% 19.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.234B $1.275B
YoY Change 1.23% -37.13%
Accrued Expenses $3.304B $3.210B
YoY Change -16.33% -11.67%
Deferred Revenue $1.133B $861.0M
YoY Change 25.75% 14.65%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.227B $546.0M
YoY Change 80.08% -74.18%
Total Short-Term Liabilities $7.765B $5.032B
YoY Change -4.84% -35.3%
LONG-TERM LIABILITIES
Long-Term Debt $7.632B $7.610B
YoY Change -6.46% -7.86%
Other Long-Term Liabilities $4.561B $3.506B
YoY Change 49.2% 5.6%
Total Long-Term Liabilities $12.19B $11.12B
YoY Change 8.71% -4.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.765B $5.032B
Total Long-Term Liabilities $12.19B $11.12B
Total Liabilities $19.96B $16.15B
YoY Change 3.0% -36.19%
SHAREHOLDERS EQUITY
Retained Earnings $39.91B $40.07B
YoY Change 32.7% 42.84%
Common Stock $477.0M $477.0M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.67B
YoY Change 11.52%
Treasury Stock Shares
Shareholders Equity $20.67B $20.69B
YoY Change
Total Liabilities & Shareholders Equity $46.51B $42.75B
YoY Change 28.34% 19.83%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $142.0M $744.0M
YoY Change -93.91% 0.54%
Depreciation, Depletion And Amortization $422.0M $271.0M
YoY Change 62.31% -14.51%
Cash From Operating Activities $415.0M -$643.0M
YoY Change -0.72% -152.83%
INVESTING ACTIVITIES
Capital Expenditures $77.00M $169.0M
YoY Change 30.51% -186.22%
Acquisitions $8.339B
YoY Change
Other Investing Activities $37.00M -$516.0M
YoY Change 60.87% 216.56%
Cash From Investing Activities -$8.452B -$685.0M
YoY Change -392.86% 90.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities $2.055B -521.0M
YoY Change -170.98% -65.47%
NET CHANGE
Cash From Operating Activities $415.0M -643.0M
Cash From Investing Activities -$8.452B -685.0M
Cash From Financing Activities $2.055B -521.0M
Net Change In Cash -$5.975B -1.849B
YoY Change -1379.44% 184.02%
FREE CASH FLOW
Cash From Operating Activities $415.0M -$643.0M
Capital Expenditures $77.00M $169.0M
Free Cash Flow $338.0M -$812.0M
YoY Change -5.85% -157.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Profit Loss
ProfitLoss
2326000000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
132000000 usd
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000032604
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
571700000 shares
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1753000000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1030000000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1277000000 usd
CY2022Q4 emr Other Deductions Net
OtherDeductionsNet
120000000 usd
CY2023Q4 emr Other Deductions Net
OtherDeductionsNet
487000000 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
20000000 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
40000000 usd
CY2022Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-48000000 usd
CY2023Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-44000000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
422000000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
139000000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98000000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
324000000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
132000000 usd
CY2022Q4 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
966000000 usd
CY2023Q4 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
0 usd
CY2022Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
2002000000 usd
CY2023Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
0 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
2326000000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
132000000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5000000 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10000000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
2331000000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
142000000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
329000000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
142000000 usd
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
2002000000 usd
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
2331000000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
142000000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.56
CY2023Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.25
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
3.43
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.99
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.56
CY2023Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.25
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
3.41
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.97
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
583600000 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
570800000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
586700000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
573300000 shares
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
241000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
174000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
16000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
12000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
10000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
235000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
165000000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2561000000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
297000000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-8000000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2561000000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
305000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8051000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2076000000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
112000000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2518000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2759000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2006000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2432000000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1244000000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1399000000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
13819000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
8666000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2363000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2701000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
14480000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
17983000000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6263000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11270000000 usd
CY2023Q3 emr Equity Method Investments And Financing Receivable After Allowance For Credit Loss
EquityMethodInvestmentsAndFinancingReceivableAfterAllowanceForCreditLoss
3255000000 usd
CY2023Q4 emr Equity Method Investments And Financing Receivable After Allowance For Credit Loss
EquityMethodInvestmentsAndFinancingReceivableAfterAllowanceForCreditLoss
3253000000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2566000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2640000000 usd
CY2023Q3 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
26564000000 usd
CY2023Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
35146000000 usd
CY2023Q3 us-gaap Assets
Assets
42746000000 usd
CY2023Q4 us-gaap Assets
Assets
46513000000 usd
CY2023Q3 us-gaap Debt Current
DebtCurrent
547000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
3227000000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1275000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1234000000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3210000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3304000000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5032000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7765000000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7610000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7632000000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3506000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4561000000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
953400000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
953400000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
572000000.0 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
571700000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
477000000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
477000000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62000000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
140000000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
40070000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39910000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1253000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1090000000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
381400000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
381700000 shares
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
18667000000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
18763000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
20689000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
20674000000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
5909000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
5881000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26598000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26555000000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42746000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46513000000 usd
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.52
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.525
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
16714000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26555000000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
2326000000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
132000000 usd
CY2022Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
2002000000 usd
CY2023Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
0 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
260000000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
422000000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
102000000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
74000000 usd
CY2022Q4 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
0 usd
CY2023Q4 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
231000000 usd
CY2022Q4 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
289000000 usd
CY2023Q4 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
247000000 usd
CY2022Q4 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-95000000 usd
CY2023Q4 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-168000000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
302000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
444000000 usd
CY2022Q4 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
116000000 usd
CY2023Q4 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-29000000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
418000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
415000000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
59000000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
77000000 usd
CY2022Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8339000000 usd
CY2022Q4 emr Proceeds From Subordinated Interest
ProceedsFromSubordinatedInterest
15000000 usd
CY2023Q4 emr Proceeds From Subordinated Interest
ProceedsFromSubordinatedInterest
0 usd
CY2022Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
23000000 usd
CY2023Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
37000000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-67000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-8453000000 usd
CY2022Q4 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
2953000000 usd
CY2023Q4 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
1000000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2886000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8452000000 usd
CY2022Q4 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-539000000 usd
CY2023Q4 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
2647000000 usd
CY2022Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
9000000 usd
CY2023Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2022Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
306000000 usd
CY2023Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
300000000 usd
CY2022Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2000000000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
175000000 usd
CY2022Q4 emr Payments For Repurchase Of Common Stock By Subsidiary
PaymentsForRepurchaseOfCommonStockBySubsidiary
0 usd
CY2023Q4 emr Payments For Repurchase Of Common Stock By Subsidiary
PaymentsForRepurchaseOfCommonStockBySubsidiary
72000000 usd
CY2022Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-41000000 usd
CY2023Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-45000000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2895000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2055000000 usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58000000 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
467000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5975000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1804000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8051000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2271000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2076000000 usd
CY2022Q4 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-78000000 usd
CY2023Q4 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-94000000 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
193000000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
97000000 usd
CY2022Q4 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-14000000 usd
CY2023Q4 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
3000000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-58000000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-89000000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-130000000 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-152000000 usd
CY2022Q4 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
289000000 usd
CY2023Q4 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
247000000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1453000000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1502000000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
897000000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1225000000 usd
CY2023Q3 emr Net Contract Assets Liabilities
NetContractAssetsLiabilities
556000000 usd
CY2023Q4 emr Net Contract Assets Liabilities
NetContractAssetsLiabilities
277000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
200000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
368000000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
8800000000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.75
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
583600000 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
570800000 shares
CY2022Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3100000 shares
CY2023Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2500000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
586700000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
573300000 shares
CY2023Q4 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
130000000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
1113000000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
731000000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
150000000 usd
CY2022Q4 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
2780000000 usd
CY2022Q4 emr Disposal Group Including Discontinued Operations Other Income Deductions Net
DisposalGroupIncludingDiscontinuedOperationsOtherIncomeDeductionsNet
44000000 usd
CY2022Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
2968000000 usd
CY2022Q4 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
966000000 usd
CY2022Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
2002000000 usd
CY2022Q4 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
116000000 usd
CY2023Q4 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-29000000 usd
CY2022Q4 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
2953000000 usd
CY2023Q4 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
1000000 usd
CY2023Q4 emr Effective Income Tax Rate Reconciliation Nondeductible Expense Per Share
EffectiveIncomeTaxRateReconciliationNondeductibleExpensePerShare
0.10
CY2023Q4 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.16
CY2022Q4 emr Unfavorable Impact Of Russia Divestiture Percentage Impact
UnfavorableImpactOfRussiaDivestiturePercentageImpact
0.02
CY2022Q4 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
12000000 usd
CY2023Q4 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
9000000 usd
CY2022Q4 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
54000000 usd
CY2023Q4 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
55000000 usd
CY2022Q4 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
71000000 usd
CY2023Q4 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
74000000 usd
CY2022Q4 emr Defined Benefit Plan Net Amortization
DefinedBenefitPlanNetAmortization
-20000000 usd
CY2023Q4 emr Defined Benefit Plan Net Amortization
DefinedBenefitPlanNetAmortization
-14000000 usd
CY2022Q4 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-25000000 usd
CY2023Q4 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-24000000 usd
CY2022Q4 emr Amortization Of Intangibles Intellectual Property And Customer Relationships
AmortizationOfIntangiblesIntellectualPropertyAndCustomerRelationships
118000000 usd
CY2023Q4 emr Amortization Of Intangibles Intellectual Property And Customer Relationships
AmortizationOfIntangiblesIntellectualPropertyAndCustomerRelationships
274000000 usd
CY2022Q4 us-gaap Restructuring Charges
RestructuringCharges
10000000 usd
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
83000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
17983000000 usd
CY2022Q4 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023Q4 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
80000000 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
7000000 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-34000000 usd
CY2022Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
4000000 usd
CY2023Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36000000 usd
CY2022Q4 emr Russia Business Exit Loss Excluding Restructuring Expense
RussiaBusinessExitLossExcludingRestructuringExpense
47000000 usd
CY2023Q4 emr Russia Business Exit Loss Excluding Restructuring Expense
RussiaBusinessExitLossExcludingRestructuringExpense
0 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
44000000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000000 usd
CY2022Q4 emr Other Deductions Net
OtherDeductionsNet
120000000 usd
CY2023Q4 emr Other Deductions Net
OtherDeductionsNet
487000000 usd
CY2022Q4 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
35000000 usd
CY2022Q4 us-gaap Restructuring Charges
RestructuringCharges
10000000 usd
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
83000000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
87000000 usd
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
83000000 usd
CY2023Q4 us-gaap Payments For Restructuring
PaymentsForRestructuring
59000000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
111000000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98000000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.05
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23
CY2023Q4 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
57000000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
446000000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
624000000 usd
CY2023Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1560000000 usd
CY2023Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1808000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2006000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2432000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5524000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5953000000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3161000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3252000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2363000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2701000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
14480000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10111000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15481000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3848000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4211000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6263000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11270000000 usd
CY2022Q4 us-gaap Depreciation
Depreciation
74000000 usd
CY2023Q4 us-gaap Depreciation
Depreciation
79000000 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
49000000 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
49000000 usd
CY2022Q4 emr Amortization Of Intangibles Excluding Capitalized Software
AmortizationOfIntangiblesExcludingCapitalizedSoftware
167000000 usd
CY2023Q4 emr Amortization Of Intangibles Excluding Capitalized Software
AmortizationOfIntangiblesExcludingCapitalizedSoftware
323000000 usd
CY2022Q4 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
19000000 usd
CY2023Q4 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
20000000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
260000000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
422000000 usd
CY2023Q3 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
995000000 usd
CY2023Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
1024000000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
550000000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
635000000 usd
CY2023Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
559000000 usd
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
606000000 usd
CY2023Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
100000000 usd
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
98000000 usd
CY2023Q3 us-gaap Recorded Third Party Environmental Recoveries Receivable
RecordedThirdPartyEnvironmentalRecoveriesReceivable
53000000 usd
CY2023Q4 us-gaap Recorded Third Party Environmental Recoveries Receivable
RecordedThirdPartyEnvironmentalRecoveriesReceivable
50000000 usd
CY2023Q4 emr Lessee Operating Lease Lease Not Yet Commenced Number Of Contracts
LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts
1 operating_lease
CY2023Q4 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P15Y
CY2023Q4 emr Lessee Operating Lease Lease Not Yet Commenced Undiscounted Future Minimum Payments
LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedFutureMinimumPayments
80000000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
861000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1133000000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
618000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
499000000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
207000000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
274000000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
144000000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
157000000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
84000000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
73000000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1959000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2827000000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
404000000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
465000000 usd
CY2023Q3 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
435000000 usd
CY2023Q4 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
449000000 usd
CY2023Q3 us-gaap Liability For Asbestos And Environmental Claims Gross
LiabilityForAsbestosAndEnvironmentalClaimsGross
173000000 usd
CY2023Q4 us-gaap Liability For Asbestos And Environmental Claims Gross
LiabilityForAsbestosAndEnvironmentalClaimsGross
169000000 usd
CY2022Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
4000000 usd
CY2023Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
18000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-111000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-47000000 usd
CY2023Q4 emr Notes Receivable Fair Value Compared With Carrying Value
NotesReceivableFairValueComparedWithCarryingValue
-100000000 usd
CY2023Q4 emr Fair Value Long Term Debt Compared With Carrying Value
FairValueLongTermDebtComparedWithCarryingValue
847000000 usd
CY2023Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
0 usd
CY2023Q4 emr Collateral Held From Counterparties
CollateralHeldFromCounterparties
0 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
28000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
13000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
4000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
2000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-3000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-2000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1255000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1090000000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3373000000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4117000000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
422000000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
139000000 usd
CY2023Q4 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
231000000 usd
CY2023Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
35000000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
260000000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
422000000 usd
CY2022Q4 emr Revenue From Contract With Customer Excluding Assessed Tax And Intersegment Eliminations
RevenueFromContractWithCustomerExcludingAssessedTaxAndIntersegmentEliminations
3388000000 usd
CY2023Q4 emr Revenue From Contract With Customer Excluding Assessed Tax And Intersegment Eliminations
RevenueFromContractWithCustomerExcludingAssessedTaxAndIntersegmentEliminations
4136000000 usd
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
emr-20231231_def.xml Edgar Link unprocessable
emr-20231231_pre.xml Edgar Link unprocessable
0000032604-24-000008-index-headers.html Edgar Link pending
0000032604-24-000008-index.html Edgar Link pending
0000032604-24-000008.txt Edgar Link pending
0000032604-24-000008-xbrl.zip Edgar Link pending
emr-20231231.htm Edgar Link pending
emr-20231231.xsd Edgar Link pending
emr-20231231_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q1fy24exhibit102.htm Edgar Link pending
q1fy24exhibit103.htm Edgar Link pending
q1fy24exhibit31.htm Edgar Link pending
q1fy24exhibit32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
emr-20231231_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
emr-20231231_cal.xml Edgar Link unprocessable
emr-20231231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable